-
公开(公告)号：US20210221877A1
公开(公告)日：2021-07-22
申请号：US17151860
申请日：2021-01-19
申请人： Bioverativ USA Inc.
摘要： The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-me-diated disorders. The present disclosure provides methods of treating complement-mediated disorders.
-
公开(公告)号：US11851482B2
公开(公告)日：2023-12-26
申请号：US17151860
申请日：2021-01-19
申请人： Bioverativ USA Inc.
CPC分类号： C07K16/18 , C07K16/40 , A61K2039/505 , C07K2317/24 , C07K2317/33 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要： The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
-
公开(公告)号：US10934347B2
公开(公告)日：2021-03-02
申请号：US16091447
申请日：2017-04-03
申请人： Bioverativ USA Inc.
IPC分类号： C07K16/18 , A61K39/395 , C07K16/40 , A61K39/00
摘要： The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
-
公开(公告)号：US20190153079A1
公开(公告)日：2019-05-23
申请号：US16091447
申请日：2017-04-03
申请人： Bioverativ USA Inc.
IPC分类号： C07K16/18
摘要： The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
